Enzymatic hydrolysis of casein leads to the generation of peptides with bioactive properties (1) . We have previously reported that the addition of transglutaminase (TGase) prior to hydrolysis with Prolyve yielded cross-linked sodium caseinate (NaCN) hydrolysates that demonstrated anti-inflammatory properties in Jurkat T cells (2) . However, hydrolysates may need to be absorbed by the intestinal epithelial cells to be functional. The aim of the present study was to assess the bioavailability of these TGase cross-linked NaCN hydrolysates using a Caco-2 cell model.
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Caco-2 cells were allowed to differentiate for 21 days in Transwell ® plates. Hydrolysate samples (2 % (v/v)) were diluted in 1·5 ml Hank's Balanced Solution (HBBS) and added to the apical side of the monolayers, while 1·5 ml HBBS without samples was added in the basolateral chamber. Chambers were then incubated at 37°C for 120 min and the apical and basolateral samples were taken and stored at −18°C until further analysis. Peptide transport was analysed by quantifying the amino nitrogen transported from the apical to the basolateral chamber using the TNBS method (3) . The non-cross linked hydrolysate (Prolyve) and cross-linking pre-hydrolysis (TGase/Prolyve) samples had the highest extent of transport (Fig. 1a) . Transport was significantly higher compared with NaCN (p < 0·05). Although cross-linked post hydrolysis (Prolyve/TGase) showed a high extent of transport, it was not significantly different (p > 0·05) from NaCN. Fig. 1b indicates that part of the hydrolysate amino Nitrogen was retained by the cells. The results overall confirm that hydrolysate peptides are able to pass through the epithelial intestinal barrier, however, more studies are necessary to demonstrate that the hydrolysates remain bioactive after transport.
